Literature DB >> 2840315

Characterization of the state of differentiation of six newly established human non-small-cell lung cancer cell lines.

G Bepler1, A Koehler, P Kiefer, K Havemann, K Beisenherz, G Jaques, C Gropp, M Haeder.   

Abstract

Six new non-small-cell lung cancer (NSCLC) cell lines were established directly from human tissue or indirectly via nude mouse xenografts in serum-supplemented media with success rates of 8% and 13%, respectively. They comprised one adenocarcinoma (ADLC-5M2), two squamous cell carcinomas (EPLC-32M1, EPLC-65H), two large cell carcinomas (LCLC-97TM1, LCLC-103H), and one malignant biphasic mesothelioma (MSTO-211H). All cell lines grew adherent to culture vessels with population doubling times (PDT) of 16-40 h, formed colonies in soft agarose with efficiencies of 0.1%-5.1%, and all grew in athymic nude mice. Xenograft histologies appeared as follows: (a) undifferentiated carcinomas with feeble resemblance to the original tumors in the case of adenocarcinomas and squamous cell carcinomas; (b) large cell carcinoma with high resemblance to the original tumor; (c) an undifferentiated tumor with predominance of large epithelial cells and few fibrous cells in the case of mesothelioma. Human chorionic gonadotropin (HCG) was found by radioimmunoassay and high-affinity binding sites for epidermal growth factor (EGF) by radio-receptor assay in 4/4 cell lines. A very low activity of L-DOPA decarboxylase (DDC) was detectable only in the adenocarcinoma cell line. All cell lines overexpressed the c-myc protooncogene, and no gene rearrangement or amplification was observed. Chromosome analysis revealed modal chromosome numbers of 70-73 in ADLC-5M2, EPLC-32M1, EPLC-65H, and MSTO-211H. Cell lines derived from large cell carcinoma had modal values of 65 and 170 and a wider chromosome distribution than all other cell lines. A NSCLC specific chromosomal aberration has been undetectable until now. These cell lines may aid in elucidating the biology of NSCLC and its interrelationship to other lung tumors.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2840315     DOI: 10.1111/j.1432-0436.1988.tb00806.x

Source DB:  PubMed          Journal:  Differentiation        ISSN: 0301-4681            Impact factor:   3.880


  29 in total

1.  Immunotargeting of human small cell lung cancer xenografts in athymic mice using a monoclonal antibody (RNL-1) against a neuroendocrine-related antigen.

Authors:  E P Mijnheere; O C Boerman; J L Broers; M Klein Rot; G P Vooijs; F C Ramaekers
Journal:  Br J Cancer Suppl       Date:  1991-06

2.  Three-dimensional analysis of the substrate-dependent invasive behavior of a human lung tumor cell line with a confocal laser scanning microscope.

Authors:  A R Strohmaier; H Spring; E Spiess
Journal:  Histochem Cell Biol       Date:  1996-03       Impact factor: 4.304

3.  Combined chemo- and radiosensitivity testing with ifosfamide and ACNU in human lung cancer cell lines.

Authors:  M Wolf; M Maasberg; R Pfab; K Havemann
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

4.  Inhibition of bone morphogenetic protein signaling reduces viability, growth and migratory potential of non-small cell lung carcinoma cells.

Authors:  Jelena Mihajlović; Laura A M Diehl; Andreas Hochhaus; Joachim H Clement
Journal:  J Cancer Res Clin Oncol       Date:  2019-09-17       Impact factor: 4.553

5.  Cathepsin B and cysteine proteinase inhibitors in human lung cancer cell lines.

Authors:  H H Heidtmann; U Salge; M Abrahamson; M Bencina; L Kastelic; N Kopitar-Jerala; V Turk; T T Lah
Journal:  Clin Exp Metastasis       Date:  1997-07       Impact factor: 5.150

6.  Identification of novel candidate oncogenes and tumor suppressors in malignant pleural mesothelioma using large-scale transcriptional profiling.

Authors:  Gavin J Gordon; Graham N Rockwell; Roderick V Jensen; James G Rheinwald; Jonathan N Glickman; Joshua P Aronson; Brian J Pottorf; Matthew D Nitz; William G Richards; David J Sugarbaker; Raphael Bueno
Journal:  Am J Pathol       Date:  2005-06       Impact factor: 4.307

7.  Tetanus toxin as a marker for small-cell lung cancer cell lines.

Authors:  J Heymanns; K Neumann; K Havemann
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

8.  Expression of ADAM15 in lung carcinomas.

Authors:  A Schütz; W Härtig; M Wobus; J Grosche; Ch Wittekind; G Aust
Journal:  Virchows Arch       Date:  2005-03-09       Impact factor: 4.064

9.  Estrogen receptor β exerts tumor repressive functions in human malignant pleural mesothelioma via EGFR inactivation and affects response to gefitinib.

Authors:  Giulia Pinton; Warren Thomas; Paolo Bellini; Arcangela Gabriella Manente; Roberto E Favoni; Brian J Harvey; Luciano Mutti; Laura Moro
Journal:  PLoS One       Date:  2010-11-29       Impact factor: 3.240

10.  Nuclear A-type lamins are differentially expressed in human lung cancer subtypes.

Authors:  J L Broers; Y Raymond; M K Rot; H Kuijpers; S S Wagenaar; F C Ramaekers
Journal:  Am J Pathol       Date:  1993-07       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.